Vimarsana
Biggest News Aggregation in the World

Page 13 - Epic Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Epic Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Epic Research Today - Breaking & Trending Today

Just 20% of Ozempic and Wegovy patients keep all the weight off after stopping - in more evidence pricey drugs are lifelong commitment - Vimarsana News

Just 20% of Ozempic and Wegovy patients keep all the weight off after stopping - in more evidence pricey drugs are lifelong commitment

Only one in five patients on blockbuster weight loss drugs keep the pounds off after stopping the medication, and almost 20 percent regained the weight, a study from Epic Research found.

About 20% of former Ozempic and Wegovy users regain weight: new study - Vimarsana News

About 20% of former Ozempic and Wegovy users regain weight: new study

A new study shows that, in certain cases, about one in five patients are unable to keep off the weight they lost with help from the drug. A report published on Epic Research found that users of diabetes medications like Ozempic and Wegovy — which exploded in popularity by doubling as a weight-loss aid — found that 17.7% regained all of their weight, if not more, after they stopped taking it.

Source: nypost.com
Majority of patients maintain weight loss after stopping medication, study reveals - Vimarsana News

Majority of patients maintain weight loss after stopping medication, study reveals

A new study on weight-loss medications, showing that a majority of patients maintained or even continued to lose weight after

T2D Remission Buffers; Another Sotagliflozin Trial; More Gender-Affirming Care Bans? - Vimarsana News

T2D Remission Buffers; Another Sotagliflozin Trial; More Gender-Affirming Care Bans?

News and commentary from the endocrinology world

Warning on Compounded GLP-1s; Ketoacidosis Deaths; Axon Stim for Diabetic Nerve Pain - Vimarsana News

Warning on Compounded GLP-1s; Ketoacidosis Deaths; Axon Stim for Diabetic Nerve Pain

News and commentary from the endocrinology world